HealthQuill Drugs
A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged governments to increase surveillance.
Climate Drugs Pharma

H5N1 influenza’s spread to mammals needs ‘close monitoring’

A recent spillover to mammals of H5N1 avian influenza needed to be “monitored closely” as the WHO readies vaccines and antivirals and urged.

Read More
A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s top research institutes, Karolinska Institutet, wrote in a study.
Drugs Medical Pharma

Blood cancer therapy may help to treat ovarian cancer: Swedish scientists

A cell therapy currently used to treat blood cancers can lead to clinical studies for ovarian cancer, scientists from one of the world’s.

Read More
blue light filtering not beneficial for eye health
Drugs Pharma

Global Pharma recalls eye drops after FDA contamination warning

India-based Global Pharma Healthcare voluntarily recalled all lots of its artificial tears lubricant eye drops after the USFDA reported possible contamination.

Read More
BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA drugs.
Drugs Pharma

BioNTech to invest $43 million in new mRNA facility

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.

Read More
GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease in patients who have been on dialysis for four months.
Drugs Medical Pharma

GSK Plc gets FDA nod to make oral drug for anaemic CKD patients

GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease.

Read More
Ayurveda
Drugs Health Pharma

India’s annual budget boosts ‘ayurveda’ spend

India’s federal budgetary allocation to the so-called Ayush Ministry, which oversees traditional healing systems, has increased by 20 percent to INR3647cr.

Read More
Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion, as average per occupied bed and international patient revenues jumped.
Drugs Medical Pharma

Max Healthcare profit jumps 7%, to raise INR 42 billion in debt

Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion,.

Read More
Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.
Drugs Medical Pharma

12 African nations commit to end AIDS in children by 2030

Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.

Read More
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.
Drugs Health Pharma

Stelis Biopharma to be pure play CDMO firm, may list ‘near termâ€™ïżŒ

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

Read More
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may ease disruptions in the supply chain situation.
Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

Read More